GlassScriptPhysician profile
Kim A Bellows
NPI 1114087145
$2,211.70
in general payments reported to CMS, 2019-2025
13 companies · $1,036 in 2025
The $1,036 reported for 2025 was more than what 81% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $85.02 · 2022: $229 · 2023: $591 · 2024: $270 · 2025: $1,036.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,897.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,116.83 | 2022-2025 | Proclaim, Eterna |
| Abbvie INC. | $575.11 | 2021-2025 | |
| Boston Scientific Corporation | $123.49 | 2024-2025 | Intracept |
| Vertex Pharmaceuticals Incorporated | $102.57 | 2025 | |
| Spr Therapeutics, INC | $52.86 | 2025 | Sprint Pns System |
| Mml US, INC. | $48.11 | 2025 | Reactiv8 |
| Medtronic, INC. | $47.66 | 2022-2025 | Inceptiv |
| Merz Pharmaceuticals, LLC | $44.56 | 2022-2024 | Xeomin |
| Fidia Pharma USA INC. | $26.21 | 2025 | Hymovis |
| Spinal Simplicity, LLC | $24.93 | 2025 | Ha Minuteman G3-R |
| Nalu Medical, INC. | $18.81 | 2021 | |
| Curonix LLC | $16.69 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Allergan, INC. | $13.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kim Bellows listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.